Accessibility Menu

Genelux

(NASDAQ) GNLX

Current Price$3.06
Market Cap$136.76M
Since IPO (2023)-50%
5 YearN/A
1 Year+24%
1 Month+22%

Genelux Financials at a Glance

Market Cap

$136.76M

Revenue (TTM)

$8.00K

Net Income (TTM)

-$31.78M

EPS (TTM)

-$0.85

P/E Ratio

-3.57

Dividend

$0.00

Beta (Volatility)

1.46 (Average)

Price

$3.06

Volume

115,163

Open

$3.08

Previous Close

$3.05

Daily Range

$3.02 - $3.09

52-Week Range

$2.29 - $8.54

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genelux

Industry

Biotechnology

Employees

26

CEO

Thomas D. Zindrick

Headquarters

Westlake Village, CA 91361, US

GNLX Financials

Key Financial Metrics (TTM)

Gross Margin

-36%

Operating Margin

-4220%

Net Income Margin

-3972%

Return on Equity

-127%

Return on Capital

-1%

Return on Assets

-98%

Earnings Yield

-28.01%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$136.76M

Shares Outstanding

44.84M

Volume

115.16K

Avg. Volume

186.62K

Financials (TTM)

Gross Profit

-$566.00K

Operating Income

-$33.21M

EBITDA

-$32.64M

Operating Cash Flow

-$25.27M

Capital Expenditure

-$1.10M

Free Cash Flow

-$26.37M

Cash & ST Invst.

$14.60M

Total Debt

$1.69M

Genelux Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$1.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$136.76M

N/A

Market Cap/Employee

$5.70M

N/A

Employees

24

N/A

Net Income

-$7.13M

+4.9%

EBITDA

-$8.32M

-8.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$23.71M

-28.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$2.18M

+50.3%

Short Term Debt

$316.00K

-6.2%

Return on Assets

-98.17%

N/A

Return on Invested Capital

-1.35%

N/A

Free Cash Flow

-$6.98M

-27.7%

Operating Cash Flow

-$6.06M

-11.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALDXAldeyra Therapeutics, Inc.
$1.75+0.00%
MREOMereo BioPharma Group plc
$0.34-0.29%
ACIUAC Immune S.A.
$2.66-3.27%
SLNSilence Therapeutics plc
$6.90+0.58%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCEVirgin Galactic
$6.18+0.36%
FFord Motor Company
$17.44+0.05%
ONDSOndas
$13.22-0.00%
NOKNokia
$14.84-0.03%

Questions About GNLX

What is the current price of Genelux?

Genelux is trading at $3.05 per share.

What is the 52-week range for Genelux?

Over the past 52 weeks, Genelux has traded between $2.29 and $8.54.

How much debt does Genelux have?

As of the most recent reporting period, Genelux reported total debt of $2.50M.

How much cash does Genelux have on hand?

Genelux reported $9.27M in cash and cash equivalents in its most recent financial results.

What is Genelux’s dividend yield?

Genelux does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.